Mortality rate in so-called "metformin-associated lactic acidosis": A review of the data since the 1960s

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 11, 2014, Pages 1123-1127

  Kajbaf, Farshad ^a   Lalau, Jean Daniel ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Lactate; Lactic acidosis; Metformin; Pharmacoepidemiology; Prognosis; Type 2 diabetes

Indexed keywords

LACTIC ACID; METFORMIN; ANTIDIABETIC AGENT;

ARTICLE; DRUG SURVEILLANCE PROGRAM; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; METFORMIN ASSOCIATED LACTIC ACIDOSIS; MORTALITY; PH; PRIORITY JOURNAL; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE;

ACIDOSIS, LACTIC; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; METFORMIN; PHARMACOVIGILANCE;

EID: 84920450301     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3689     Document Type: Article

References (25)

1. Hermann LS. Metformin: a review of its pharmacological properties and therapeutic use. Diabetes Metab 1979; 5(3): 233-245.
2. Schwarzbeck A, Hastka J, Kühnle F, Rambausek M. Metformin-associated lactic acidosis in diabetic patients with acute renal failure. Nephrol Dial Transplant 1995; 10(3): 425-426.
3. Wiholm BE, Myrhed M. Metformin-associated lactic acidosis in Sweden 1977-1991. Eur J Clin Pharmacol 1993; 44(6): 589-591.
4. Gottlieb B, Auld WH. Metformin in treatment of diabetes mellitus. Br Med J 1962; 1(5279): 680-682.
5. Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994; 30(3): 187-228.
6. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA. Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 1998; 338(4): 265-266.
7. Spiller HA, Quadrani DA. Toxic effects from metformin exposure. Ann Pharmacother 2004; 38(5): 776-780.
8. Peters N, Jay N, Barraud D, et al. Metformin-associated lactic acidosis in an intensive care unit. Crit Care 2008; 12(6): R149.
9. Seidowsky A, Nseir S, Houdret N, Fourrier F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009; 37(7): 2191-2196.
10. Yeung CW, Chung HY, Fong BM, et al. Metformin-associated lactic acidosis in Chinese patients with type II diabetes. Pharmacology 2011; 88(5-6): 260-265.
11. Scale T, Harvey JN. Diabetes, metformin and lactic acidosis. Clin Endocrinol (Oxf) 2011; 74(2): 191-196.
12. Li Cavoli G, Tortorici C, Bono L, et al. Acute kidney injury associated with metformin. Am J Emerg Med 2011; 29(5): 568-569.
13. Arroyo D, Melero R, Panizo N, et al. Metformin-associated acute kidney injury and lactic acidosis. Int J Nephrol 2011; 2011: 749653.
14. Renda F, Mura P, Finco G, Ferrazin F, Pani L, Landoni G. Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci 2013; 17(Suppl 1): 45-49.
15. Vecchio S, Giampreti A, Petrolini VM, et al. Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol (Phila) 2014; 52(2): 129-135 [Epub 2013 Nov 28].
16. Shadnia S, Barzi F, Askari A, Hassanian-Moghaddam H, Zamani N, Ebrahimian K. Metformin toxicity: a report of 204 cases from Iran. Curr Drug Saf 2013; 8(4): 278-281.
17. Kajbaf F, Lalau JD. The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database. Diabetes Med 2013; 30(3): 345-348.
18. Kajbaf F, Lalau JD. The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis. BMC Pharmacol Toxicol 2013; 14: 22.
19. Friesecke S, Abel P, Roser M, Felix SB, Runge S. Outcome of severe lactic acidosis associated with metformin accumulation. Crit Care 2010; 14: R226.
20. Lee SW, Hong YS, Park DW, et al. Lactic acidosis not hyperlactatemia as a predictor of in hospital mortality in septic emergency patients. Emerg Med J 2008; 25(10): 659-665.
21. Lalau JD, Azzoug ML, Kajbaf F, Briet C, Desailloud R. Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation. Diabetes Metab 2014. pii: S1262-3636(13)00233-4.
22. Bonsignore A, Pozzi F, Fraternali Orcioni G, Ventura F, Palmiere C. Fatal metformin overdose: case report and postmortem biochemistry contribution. Int J Legal Med 2014; 128(3): 483-492.
23. Duong JK, Furlong TJ, Roberts DM, et al. The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis. Drug Saf 2013; 36(9): 733-746.
24. Timbrell S, Wilbourn G, Harper J, Liddle A. Lactic acidosis secondary to metformin overdose: a case report. J Med Case Rep 2012; 6(1): 230.
25. Miller DK, Brinson AJ, Catalano G, Catalano MC. Lactic acidosis, hypotension, and sensorineural hearing loss following intentional metformin overdose. Curr Drug Saf 2011; 6(5): 346-349.